alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     Textainer Equipment Income Fund VI, LP
</LEGEND>
<CIK>                         0001003638
<NAME>                        Textainer Equipment Income Fund VI, LP
<MULTIPLIER>                                   1,000
<CURRENCY>                                     US Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   JUN-30-1997
<EXCHANGE-RATE>                                1
<CASH>                                         2,130
<SECURITIES>                                   0
<RECEIVABLES>                                  1,290
<ALLOWANCES>                                   82
<INVENTORY>                                    0
<CURRENT-ASSETS>                               21
<PP&E>                                         32,145
<DEPRECIATION>                                 2,893
<TOTAL-ASSETS>                                 32,611
<CURRENT-LIABILITIES>                          1,436
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     31,175
<TOTAL-LIABILITY-AND-EQUITY>                   32,611
<SALES>                                        0
<TOTAL-REVENUES>                               2,608
<CGS>                                          0
<TOTAL-COSTS>                                  1,981
<OTHER-EXPENSES>                               60
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                567
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   567
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        

</TABLE>
IN THE MATTER OF THE PETITION

FOR REINSTATEMENT OF 

MARGOT ELIZABETH ROBERTS

TO THE BAR OF MARYLAND

*

*

*

*

*

*

 IN THE

 SUPREME COURT

 OF MARYLAND

 AG No. 4

 September Term, 2023 

ORDER

Upon consideration of Margot Elizabeth Roberts’ petition for reinstatement to the 

Bar of Maryland pursuant to Rule 19-752 and Bar Counsel’s response to the petition, it is 

this 31st day of August 2023, by the Supreme Court of Maryland, 

ORDERED that the petition is granted with a condition. Petitioner Margot 

Elizabeth Roberts is reinstated to the Bar of Maryland subject to the condition that, 

pursuant to Rule 19-752(j)(9), she shall enter into a treatment monitor agreement with Bar 

Counsel, which agreement will remain in effect until Bar Counsel recommends its 

termination and until further order of this Court; and it is further

ORDERED that, upon the parties providing proof to the Clerk that Petitioner has 

entered into a mental health monitor agreement with Bar Counsel, the Clerk shall replace 

the name Margot Elizabeth Roberts on the register of attorneys entitled to practice law in 

Maryland and certify that fact to the Trustees of the Client Protection Fund and the Clerks 

of all judicial tribunals in this State.

/s/ Matthew J. Fader

 Chief Justice
#### Batho, Respondent, vs. Bergholtz, Appellant.

For the appellant: *W. G. Haddow*of Ellsworth.

For the respondent: *White & White*of River Falls.

*By the Court.*

Judgment affirmed.
**Exhibit 23.1**

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No.’s 333-119633, 333-110292 and S-8(No.’s 333-121376, 333-98911, 333-84676, 333-84678) of Mykrolis Corporation of our report dated March 11, 2005 relating to the financial statements, financial statement schedule, management’s assessment of the effectiveness of internalcontrol over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K. 

 

Boston, Massachusetts 

March 11, 2005 

 

*Exhibit Volume Page 80 of 84*
ex10-3.htm


ANAVEX LIFE SCIENCES



 


February 2, 2011







Genesis BioPharma Group, LLC


Steve Arikian, M.D.


50 Harrison St.


Suite 315


Hoboken, NJ 07030


USA

















Re:  Notice and Acknowledgement of Termination of Anavex 2-73 Engagement with Genesis BioPharma Group, LLC (GBG)












Dear Steve:







In accordance with our conversations with you, please accept this letter as formal notice of the termination of GBG contract dated August 10, 2010 as we already discussed and agreed upon.  We understand, under mutual agreement, that GBG accepts this notice of termination due to the reasons we discussed in person with you January 22 and 23, 2011, which include the current financial situation, redundancies in work performed and delays of the Phase 1/2a program, including actual work performed by other CROs, and internal strategic shifts due to the above.  As formality, kindly indicate your acceptance of notice of this termination, as well as your agreement to the terms stated herein, as evidenced by your acknowledgement signed below.  It is intended and agreed that the Agreement shall be terminated as of the effective date of this termination notice.


Pursuant to the terms of the Agreement all proprietary and confidential information, files, equipment and materials of Anavex Life Sciences should be immediately returned to Anavex.







It is further understood and agreed by the parties that a final payment is to be made to GBG by Anavex Life Sciences Corp. and represents the final compensation to which both parties agreed upon in negotations:







$ 45,000.00







This sum shall be paid to you  by February 5th, 2011 as follows:







Upon execution of this letter-agreement and full payment of the sum set forth hereinabove, Anavex shall have no further obligations and you shall have no further claims or rights to compensation.   This Acknowledgment shall constitute a Release of any and all claims.






  





  











  








However, Anavex intends to continue with the separate sub-lease agreement of the office-space at 50 Harrison street, Suite 315, Hoboken, NJ 07030 under the stipulations as agreed upon in that separate agreement.







The amount of $ 45,000 will be wired directly to your e-Trade account.







Kindly indicate your acknowledgement and agreement as to the terms set forth herein by signing where indicated below.







If you should have any questions with regard to this matter, please do not hesitate to contact me.



























Sincerely,












/s/ Harvey Lalach


Harvey Lalach


President
































The undersigned hereby acknowledges receipt of this notice


and agrees to the terms set forth herein.












/s/ Steve Arikian                                                      Date:           February 2, 2011                                                      


Genesis BioPharma Group, LLC


Steve Arikian, M.D., CEO
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         513,802
<SECURITIES>                                         0
<RECEIVABLES>                                  637,085
<ALLOWANCES>                                  (40,000)
<INVENTORY>                                  1,478,632
<CURRENT-ASSETS>                             2,708,145
<PP&E>                                       2,077,865
<DEPRECIATION>                             (1,972,171)
<TOTAL-ASSETS>                               4,786,010
<CURRENT-LIABILITIES>                        2,063,247
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    16,964,504
<OTHER-SE>                                (15,749,736)
<TOTAL-LIABILITY-AND-EQUITY>                 1,214,768
<SALES>                                        344,069
<TOTAL-REVENUES>                               816,352
<CGS>                                          190,900
<TOTAL-COSTS>                                  538,725
<OTHER-EXPENSES>                               834,720
<LOSS-PROVISION>                              (10,000)
<INTEREST-EXPENSE>                            (70,334)
<INCOME-PRETAX>                              (596,993)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (536,993)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (596,993)
<EPS-PRIMARY>                                  $(0.10)
<EPS-DILUTED>                                        0
        

</TABLE>
Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion *

should not be published and is not precedent except under the limited

circumstances set forth in 5TH CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 09-40610

Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

MARCEL DELON GOODMAN,

Defendant-Appellant.

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 2:09-CR-144-1

Before JOLLY, WIENER, and ELROD, Circuit Judges.

PER CURIAM:*

Marcel Delon Goodman appeals the 51-month sentence imposed pursuant

to his guilty plea conviction for transporting an undocumented alien in the

United States. Goodman argues that the district court clearly erred in applying

the reckless endangerment enhancement, pursuant to U.S.S.G. § 2L1.1(b)(6),

because he had not placed the transported aliens at a substantial risk of death

United States Court of Appeals

Fifth Circuit

F I L E D

December 31, 2009

Charles R. Fulbruge III

Clerk
No. 09-40610

2

or serious bodily injury. He argues that there were no aggravating factors

involved in transporting the aliens that warranted the enhancement.

A defendant’s offense level may be increased to 18 if the offense involved

the defendant intentionally and recklessly creating a substantia risk of death or

harm to another person. § 2L1.1(b)(6). Although there is no single bright-line

test for determining the applicability of this adjustment, this court has provided

a non-exhaustive list of five factors to consider when applying this adjustment:

“the availability of oxygen, exposure to temperature extremes, the aliens’ ability

to communicate with the driver of the vehicle, their ability to exit the vehicle

quickly, and the danger to them if an accident occurs.” United States v. ZunigaAmezquita, 468 F.3d 886, 889 (5th Cir. 2006).

Generally, carrying passengers in the cargo area of a sports utility vehicle

(SUV) would not justify a reckless endangerment enhancement, see id. at 889,

however, the district court found a number of aggravating factors to support the

enhancement in Goodman’s case. Based on the sworn statements of the aliens

and the photographs introduced into evidence, the district court found the

following relevant factors: insufficient oxygen, extreme temperatures, the

aliens’s inability to communicate with the driver, and their inability to extricate

themselves quickly from the cargo area. Although Goodman disagreed with the

statements of the aliens, the district court’s findings were plausible in light of

the record presented. Cf. United States v. Angeles-Mendoza, 407 F.3d 742, 750

(5th Cir. 2005).

In light of the evidence presented, the district court did not clearly err in

determining that the four aliens who were “crammed” on their sides on the floor

of the cargo area of a SUV vehicle, underneath a blanket and other objects, were

placed at a substantial risk of harm that justified the enhancement for reckless

endangerment. The sentence is AFFIRMED.
Exhibit 32.2

Certification of CEO and CFO Furnished Pursuant to 18 U.S.C. Section 1350,

As Adopted
Pursuant To

Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the Annual Report of NetLogic Microsystems, Inc. (the Company) on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission on the date
hereof, I, Donald Witmer, Chief Financial Officer of the Company, certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to the best of my knowledge,

(i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2006 (the Report), fully complies with the
requirements of section 13(a) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Company.



/s/ DONALD WITMERDonald Witmer Vice PresidentFinance and Chief Financial Officer March 2, 2007


A signed original of this written statement required by Section 906 has been provided
to the Company and will be retained by the Company and furnished to the Securities
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         November 29, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean C. Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on November 19, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail Express, Priority Mail & USPS Ground Advantage® Contract 758 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2025-449, K2025-446.                

Sean C. Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-27909 Filed 11-27-24; 8:45 am]

BILLING CODE 7710-12-P
# L_2015275EN.01000301.xml

| 20.10.2015 | EN | Official Journal of the European Union | L 275/3 |
| --- | --- | --- | --- |

20.10.2015

EN

Official Journal of the European Union

L 275/3

---

COMMISSION IMPLEMENTING REGULATION (EU) 2015/1865

of 7 October 2015

entering a name in the register of protected designations of origin and protected geographical indications (Cipolla bianca di Margherita (PGI))

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs (1), and in particular Article 52(2) thereof,

Whereas:

| (1) | Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, Italy's application to register the name ‘Cipolla bianca di Margherita’ was published in the Official Journal of the European Union (2). |
| --- | --- |

(1)

Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, Italy's application to register the name ‘Cipolla bianca di Margherita’ was published in the Official Journal of the European Union (2).

| (2) | As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Cipolla bianca di Margherita’ should therefore be entered in the register, |
| --- | --- |

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Cipolla bianca di Margherita’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Cipolla bianca di Margherita’ (PGI) is hereby entered in the register.

The name specified in the first paragraph denotes a product in Class 1.6. — Fruit, vegetables and cereals, fresh or processed, as listed in Annex XI to Commission Implementing Regulation (EU) No 668/2014 (3).

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 October 2015.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 343, 14.12.2012, p. 1.

1

(2)  
  OJ C 189, 6.6.2015, p. 17.

2

(3)  Commission Implementing Regulation (EU) No 668/2014 of 13 June 2014 laying down rules for the application of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs (OJ L 179, 19.6.2014, p. 36).

3

---
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002

In connection with the Annual
Report of Precision Drilling Corporation on Form 40-F for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the Report), the
undersigned President and Chief Executive Officer of Precision Drilling Corporation, hereby certifies, to such officers knowledge, that:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Precision Drilling Corporation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dated: March 10, 2017



|    |  |                                                                                      
|--- |  | -------------------------------------------------------------------------------------
|By: |  | /s/ Kevin A. Neveu                                                                   
|    |  | Kevin A. Neveu, President & Chief Executive Officer of Precision Drilling Corporation
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Precision Drilling Corporation on
Form 40-F for the year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned Chief Financial Officer of Precision Drilling Corporation, hereby
certifies, to such officers knowledge, that:



|1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Precision
Drilling Corporation.
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                          |  | 
|------------------------------------------------------------------------- |  | 
|By:  /s/  Robert McNally                                                  |  | 
|Robert McNally, Chief Financial Officer of Precision Drilling Corporation
|                                                                          | 
|March 19, 2013                                                            |  |
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_____________________ No. 98-10546

_____________________ IN THE MATTER OF: THE WAY APARTMENTS DT, Debtor. BEAL BANK SSB, Appellee,
v. THE WAY APARTMENTS DT, Appellant.

_________________________________________________________________

Appeal from the United States District Court for the Northern District of Texas, Ft. Worth

(4:98-CV-12-A)

_________________________________________________________________ January 8, 1999 Before POLITZ, Chief Judge, KING, and BENAVIDES, Circuit Judges. PER CURIAM: * We affirm the judgment of the district court for essentially the reasons given in its Memorandum Opinion and Order filed April 1, 1998. The mandate shall issue forthwith. AFFIRMED.
<PAGE>   1


EXHIBIT 11.

                                 ENDOCARE, INC.
                        CALCULATION OF EARNINGS PER SHARE


<TABLE>
<CAPTION>
                                                 Three Months Ended
                                                   March 31, 1997
                                                 ------------------

<S>                                                 <C>          
Net loss                                            $   (739,454)
                                                   ==============

Weighted average number of common
shares outstanding during the period                    7,439,048
                                                        =========

Primary net loss per share                                $ (.10)
                                                         ========

Fully diluted net loss per share                          $ (.10)
                                                         ========
</TABLE>










        The effect of potential exercise of common stock options and warrants is
        not included in these calculations because such effect would be
        anti-dilutive.



                                      -17-